Bioteque (4107) - Total Liabilities
Based on the latest financial reports, Bioteque (4107) has total liabilities worth NT$1.05 Billion TWD (≈ $33.17 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Bioteque - Total Liabilities Trend (2006–2025)
This chart illustrates how Bioteque's total liabilities have evolved over time, based on quarterly financial data. See 4107 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Bioteque Competitors by Total Liabilities
The table below lists competitors of Bioteque ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Greenpanel Industries Limited
NSE:GREENPANEL
|
India | Rs6.91 Billion |
|
Y.U.D. Yangtze River Investment Industry Co Ltd
SHG:600119
|
China | CN¥275.07 Million |
|
Hold-Key Electric Wire & Cable Co Ltd
TW:1618
|
Taiwan | NT$1.96 Billion |
|
HUA YU LIEN Development Co Ltd
TW:1436
|
Taiwan | NT$14.73 Billion |
|
Erdene Resource Development Corp
TO:ERD
|
Canada | CA$1.55 Million |
|
Sirca Paints India Limited
NSE:SIRCA
|
India | Rs1.17 Billion |
|
Socep Constant
RO:SOCP
|
Romania | RON316.26 Million |
|
Platinum Asia Investments Ltd
AU:PAI
|
Australia | AU$12.09 Million |
Liability Composition Analysis (2006–2025)
This chart breaks down Bioteque's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 4107 market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.27 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bioteque's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bioteque (2006–2025)
The table below shows the annual total liabilities of Bioteque from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | NT$1.05 Billion ≈ $33.17 Million |
-12.59% |
| 2024-12-31 | NT$1.20 Billion ≈ $37.95 Million |
-15.79% |
| 2023-12-31 | NT$1.43 Billion ≈ $45.06 Million |
-1.26% |
| 2022-12-31 | NT$1.45 Billion ≈ $45.64 Million |
+36.95% |
| 2021-12-31 | NT$1.06 Billion ≈ $33.32 Million |
+17.58% |
| 2020-12-31 | NT$899.55 Million ≈ $28.34 Million |
+98.85% |
| 2019-12-31 | NT$452.37 Million ≈ $14.25 Million |
-1.12% |
| 2018-12-31 | NT$457.51 Million ≈ $14.41 Million |
-5.61% |
| 2017-12-31 | NT$484.69 Million ≈ $15.27 Million |
-0.35% |
| 2016-12-31 | NT$486.40 Million ≈ $15.32 Million |
-19.75% |
| 2015-12-31 | NT$606.13 Million ≈ $19.10 Million |
+30.29% |
| 2014-12-31 | NT$465.21 Million ≈ $14.66 Million |
+22.08% |
| 2013-12-31 | NT$381.06 Million ≈ $12.01 Million |
+11.13% |
| 2012-12-31 | NT$342.89 Million ≈ $10.80 Million |
-11.48% |
| 2011-12-31 | NT$387.34 Million ≈ $12.20 Million |
-12.33% |
| 2010-12-31 | NT$441.82 Million ≈ $13.92 Million |
-6.84% |
| 2009-12-31 | NT$474.29 Million ≈ $14.94 Million |
-11.44% |
| 2008-12-31 | NT$535.56 Million ≈ $16.87 Million |
+11.95% |
| 2007-12-31 | NT$478.39 Million ≈ $15.07 Million |
-9.85% |
| 2006-12-31 | NT$530.68 Million ≈ $16.72 Million |
-- |
About Bioteque
Bioteque Corporation manufactures and sells medical devices in Asia, South America, North America, and internationally. The company offers angiography catheter, balloon dilation catheter, guiding sheath, guide steel wire, y-type connector, multi-pipe joint, connecting pipe, y-type connector assembly, peripheral vascular guiding catheter, coronary balloon dilation catheter, central venous catheter… Read more